AirSculpt Posts $7.2M Q3 Loss, Guides FY EBITDA to $9-10M
AIRS sits 50% above its 52-week low of $1.15.
Summary
AirSculpt reported a Q3 net loss of $7.2 million and adjusted EPS of -$0.08, with adjusted EBITDA of just $400 thousand, on revenue of $31.9 million and a loss per share of 10 cents. Management guided full-year revenue to $144-146 million and adjusted EBITDA to $9-10 million. The loss follows a weak Q2 in August, when the company posted a $1.1 million net loss on $42.9 million of revenue, cut its full-year EBITDA outlook, and agreed to a debt amendment requiring $5 million in near-term payments plus 50% of something tied to the amendment. That cash squeeze is the real issue here: a $400 thousand quarterly EBITDA figure leaves little room against those obligations, and the company has been leaning on its $14.8 million ATM program for liquidity. The FY EBITDA guide of $9-10 million implies a steep second-half ramp from the Q3 run rate, which is the number to test against the next quarterly report.
At the time of this announcement, AIRS was trading at $1.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $103.8M. The 52-week trading range was $1.15 to $10.63. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.